Related Experiment Videos
A predictive model for failure to control bleeding during acute variceal haemorrhage
Z Ben-Ari1, F Cardin, A P McCormick
1Liver Transplantation and Hepatobiliary Medicine, The Royal Free Hospital and School of Medicine, London, UK.
Journal of Hepatology
|September 17, 1999
Summary
Active variceal bleeding in cirrhotic patients predicts rebleeding and mortality. Early endoscopic findings like active bleeding, encephalopathy, and platelet count are key indicators for managing this complication.
Area of Science:
- Hepatology
- Gastroenterology
- Clinical Medicine
Background:
- Variceal bleeding is a common, high-risk complication of cirrhosis.
- Early rebleeding in variceal bleeding is associated with increased mortality.
- No predictive models currently exist for acute variceal bleeding outcomes.
Purpose of the Study:
- To identify predictors of failure to control bleeding (continued or early rebleeding) in cirrhotic patients.
- To develop a model for predicting 30-day mortality in patients with variceal bleeding.
- To compare bleeding control and outcomes between different treatment strategies.
Main Methods:
- Prospective evaluation of 695 consecutive cirrhotic patients with hematemesis/melaena.
- Defined criteria for failure to control bleeding (continued bleeding or rebleeding within 5 days).
- Compared two treatment groups: initial transfusion/vasopressors followed by sclerotherapy vs. immediate injection sclerotherapy; also included a non-variceal bleeding group.
Main Results:
- Failure to control bleeding occurred in 44% (group 1) and 38% (group 2) of patients with variceal bleeding.
- Independent predictors of early rebleeding included active bleeding at endoscopy, encephalopathy, platelet count, alcoholism history, hematemesis presentation, log urea, and shorter admission interval.
- Predictors of 30-day mortality were early bleeding, bilirubin, encephalopathy, shorter admission interval, and log urea.
Conclusions:
- Active variceal bleeding at diagnostic endoscopy predicts failure to control bleeding (rebleeding within 5 days).
- Failure to control bleeding is a significant predictor of 30-day mortality in cirrhotic patients.
- Sclerotherapy may independently influence bleeding risk in some patients.